Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Immunology and Infection

A subscription to JoVE is required to view this content.
You will only be able to see the first 2 minutes.

JoVE Journal Immunology and Infection
Спасение рекомбинантный Ньюкасл вирусное заболевание из кДНК
Optimization of a Quantitative Micro-neutralization Assay
Journal (Immunology and Infection)
Optimization of a Quantitative Micro-neutralization Assay
Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Journal (Immunology and Infection)
Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
 
Click here for the English version

Спасение рекомбинантный Ньюкасл вирусное заболевание из кДНК

Article DOI: 10.3791/50830
October 11th, 2013 •
1,2, 1,2,3, 4
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, 2Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, 3Department of Medicine, Icahn School of Medicine at Mount Sinai, 4Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester

Chapters

Summary
Automatic Translation
October 11th, 2013

Please note that all translations are automatically generated.

Click here for the English version.

Вируса болезни Ньюкасла (NDV) была тщательно изучена в последние несколько лет, чтобы развить новые векторы для вакцинации и терапии, среди других. Эти исследования стало возможным благодаря методов по спасению рекомбинантный вирус из кДНК, таких, как мы описываем здесь.

Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter